Dr. Lamson has over 28 years of experience in pharmacokinetics and clinical pharmacology. His therapeutic concentrations include CNS, urology, infectious diseases, and endocrinology (hormone therapy). Dr. Lamson’s strategic regulatory practice includes development of compounds through various regulatory pathways including the NDA, sNDA, ANDA, and the 505(b) 2 routes of approval. His skills also include using innovative analytical methods (modeling and simulation) to evaluate PK disposition and in vivo drug delivery performance throughout drug development.
Education